• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM VOLUX XC 2 X 1ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 20073770
Device Problem Device Appears to Trigger Rejection (1524)
Patient Problems Unspecified Infection (1930); Skin Erosion (2075)
Event Date 03/07/2023
Event Type  Injury  
Manufacturer Narrative
Suspect product: lot number 963/2.The filler was injected into the patient and is not accessible for return.The syringe has been discarded.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of infection is a known potential adverse event addressed in the product labeling.The event of extrusion is considered an unexpected adverse drug experience.
 
Event Description
Healthcare professional reported injecting a patient along the jawline with 2 cc of juvéderm® volux¿ xc.The patient ¿nodule-like bumps that when express, filler comes out.¿ it was noted that the event is ¿looking infected.¿ the event began 2 weeks later, with 1 nodule close to the chin ¿where the cannula would have stopped.¿ the patient ¿popped it and filler came out.¿ a week and a half later, 2 more lumps appears, 1 at the bottom of the jaw and 1 close to the ear.A month after injection, the patient was given keflex 3x day 500 mg x 10 days and a medrol dosepak.Once the treatment is done they may dissolve if necessary.Event is ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM VOLUX XC 2 X 1ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key16710509
MDR Text Key313006619
Report Number3005113652-2023-00233
Device Sequence Number1
Product Code LMH
UDI-Device Identifier30840228300077
UDI-Public30840228300077
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number20073770
Device Lot Number1000543811
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/26/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexFemale
Patient Weight59 KG
-
-